Thrombolytic drugs


Thrombolytic drugs
Thrombolytic drugs are used to dissolve a preexisting clot or thrombus, often in an acute or emergency situation. Some of the thrombolytic drugs currently used include alteplase, reteplase, streptokinase, tenecteplase, and urokinase.
Pharmacokinetics
After I.V. or intracoronary administration, thrombolytic drugs are distributed immediately throughout the circulation, quickly activating plasminogen (a precursor to plasmin, which dissolves fibrin clots).
Blood work
Alteplase, reteplase, tenecteplase, and urokinase are cleared rap-idly from circulating plasma, primarily by the liver. Streptokinase is removed rapidly from the circulation by antibodies and the reticuloendothelial system (a body system involved in defending against infection and disposing of products of cell breakdown). These agents don’t appear to cross the placental barrier.
Pharmacodynamics
Thrombolytic drugs convert plasminogen to plasmin, which lyses (dissolves) thrombi, fibrinogen, and other plasma proteins.

Pharmacotherapeutics
Thrombolytic drugs have a number of uses. They’re used to treat certain thromboembolic disorders (such as acute MI, acute ischemic stroke, and peripheral artery occlusion) and have also been used to dissolve thrombi in arteriovenous cannulas (used in dialysis) and I.V. catheters to reestablish blood flow.

Comments